Fibroblast Activation Protein Inhibitor (FAPI) therapy, is a relatively new and emerging approach in cancer treatment. FAPI targets fibroblast activation protein (FAP), a protein found in the tumour microenvironment. FAP is associated with tumour growth, invasion, and metastasis.
fibroblast activation protein inhibitor ([18F]F-FAPI) with that of F-18 labeled fluordesoxyglucose positron emission tomography/computed tomography ([18F]F-FDG PET/CT) in patients with lung adenocarcinoma (LAD).